Blood proteins shift during Alzheimer's treatment and may help monitor the effects of the medication

Дата публикации: 24-09-2026 22:30:01

Patients with early symptoms of Alzheimer's disease may be prescribed anti-amyloid therapy, which can help clear the sticky clumps of amyloid protein in the brain that characterize Alzheimer's. While these treatments cannot cure Alzheimer's or restore cognitive function to normal, they have been shown to slow the progression of the disease. Their effects may vary, and clinicians have had no way to monitor treatment in an individual patient besides expensive brain scans.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Alzheimer’s drugs may not work and could raise brain risks	0	8.36	04-05-2026
2	An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows	2	7	14-07-2026
3	A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it	0	8.12	17-08-2026
4	Alzheimer's blood biomarker tracks brain amyloid similarly across racial groups, study finds	0	5.79	13-10-2026
5	Scientists may have finally found how Alzheimer's spreads through the brain	0	7.51	30-06-2026
6	A hidden brain problem may be an early warning for Alzheimer’s	3	8	03-01-2026
7	The surprising therapy targeting the liver which could protect brain from Alzheimer's	0	9.85	16-06-2026
8	Copper drug clears toxic Alzheimer’s proteins and restores memory	0	9.29	15-06-2026
9	Scientists May Have Found What Really Triggers Alzheimer’s Disease	2	7	19-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.08. Источник: medicalxpress.com.